FDA expands Sanofi and Regeneron's Dupixent approval to younger children with chronic spontaneous urticaria

WuXi Biologics gains MFDS approval for three Wuxi manufacturing sites

OrganaBio and RxMP Therapeutics partner to advance RMP-402 haemostatic drug product

Université Laval and Glycovax Pharma agree exclusive global licence to develop innovative galectin-3 inhibitors

Thryv Therapeutics doses first patients in Wave II clinical study for Long QT Syndrome; THRV-1268 receives FDA Fast Track Designation

WuXi Biologics receives South Korean certification for commercial manufacturing of bispecific antibody therapeutics

PureTech Health reports positive Phase 1b data for LYT-200 in MDS and AML

European Commission approves Ojemda as first targeted therapy for relapsed paediatric low-grade glioma

Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning

Ondine Biomedical abstracts selected for 2026 World Congress on Infectious Diseases

hVIVO secures Phase III human challenge trial contract with ILiAD Biotechnologies

FDA expands approval of Sanofi's Tzield for early-stage type 1 diabetes in young children

Inhibrx provides clinical update on ozekibart (INBRX-109) for colorectal cancer treatment

Lytix reports phase II results showing durable responses in advanced melanoma

Rznomics reports RZ-001 interim clinical data in hepatocellular carcinoma at AACR 2026